NCT06299410View on ClinicalTrials.gov

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

ITI-1284 10 mg

ITI-1284 tablet

DRUG

ITI-1284 20 mg

ITI-1284 tablet

Trial Locations (1)

06520

RECRUITING

Clinical Site 1, New Haven

Sponsors
All Listed Sponsors
lead

Intra-Cellular Therapies, Inc.

INDUSTRY